Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
2007 1
2009 1
2012 1
2013 2
2015 1
2016 1
2017 2
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD.
Bhatt SP, Dransfield MT, Cockcroft JR, Wang-Jairaj J, Midwinter DA, Rubin DB, Scott-Wilson CA, Crim C. Bhatt SP, et al. Among authors: scott wilson ca. Int J Chron Obstruct Pulmon Dis. 2017 Jan 19;12:351-365. doi: 10.2147/COPD.S117373. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28176907 Free PMC article. Clinical Trial.
A randomised, phase III trial of once-daily fluticasone furoate/vilanterol 100/25 μg versus once-daily vilanterol 25 μg to evaluate the contribution on lung function of fluticasone furoate in the combination in patients with COPD.
Siler TM, Nagai A, Scott-Wilson CA, Midwinter DA, Crim C. Siler TM, et al. Among authors: scott wilson ca. Respir Med. 2017 Feb;123:8-17. doi: 10.1016/j.rmed.2016.12.001. Epub 2016 Dec 2. Respir Med. 2017. PMID: 28137501 Free article. Clinical Trial.
Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM. Cowie RL, et al. Among authors: scott wilson ca. Clin Ther. 2007 Jul;29(7):1390-402. doi: 10.1016/j.clinthera.2007.07.021. Clin Ther. 2007. PMID: 17825690 Clinical Trial.
11 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page